CTNNB1 and hepatocellular carcinoma: In addition to the Wnt-TGF-β subclass suggested by Hoshida et al., an another genetic event activating β-Catenin signaling independent of CTNNB1 mutation is AXIN1 mutation which is reported to be seen in more than 10% of HCC patients [2].